Evidence map›Paper›PMID 42261628›Full record

ReviewArchiv der Pharmazie2026

Channel Dysfunction as the Basis for Comorbidities in Multiple Sclerosis and Depression.

Nicole Rychlik, Kay Jüngling, Sven G Meuth, Thomas Budde, Marta Méndez-Couz

Abstract readReview
In one paragraph

Review in Archiv der Pharmazie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nicole RychlikDepartment of Neurology, University Hospital Münster, Münster, Germany.
Kay JünglingInstitute of Physiology I, University of Münster, Münster, Germany.
Sven G MeuthDepartment of Neurology, University Hospital Münster, Münster, Germany.
Thomas BuddeInstitute of Physiology I, University of Münster, Münster, Germany.ORCID https://orcid.org/0000-0002-5263-8183
Marta Méndez-CouzInstitute of Physiology I, University of Münster, Münster, Germany.ORCID https://orcid.org/0000-0002-8931-019X

Funding

German Research Foundation (DFG) 499442527German Research Foundation (DFG) 521379614German Research Foundation (DFG) SFB/TRR 393 subproject B02Research Training Group 'Chemical biology of ion channels (Chembion)'
6 · The paper itself

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system that is frequently accompanied by major depressive symptoms, which substantially worsen disease burden and quality of life. Increasing evidence suggests that this comorbidity is not solely a psychological reaction to neurological disability but may arise from shared neurobiological mechanisms. Ion channels play a central role in regulating neuronal excitability, synaptic transmission and immune cell function, and their dysregulation has emerged as a key feature of MS pathology. Demyelination and neuroinflammation induce profound alterations in the expression, distribution and function of several ion channel families, including hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, voltage-gated potassium channels such as K

Indexed as

DepressionIon ChannelsMultiple SclerosisAnimalsComorbidityHumansIon Channels

Identifiers

PMID42261628
PMCPMC13247730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.